Canada markets closed

NeuroSense Therapeutics Ltd. (NRSNW)

NasdaqCM - NasdaqCM Delayed Price. Currency in USD
Add to watchlist
0.1700+0.0630 (+58.88%)
At close: 04:00PM EDT
Show:
Income Statement
Balance Sheet
Annual

Cash Flow

All numbers in thousands
Breakdown
ttm
2023-12-31
2022-12-31
2021-12-31
2020-12-31
2019-12-31
Cash flows from operating activities
Net Income
-11,280
-11,280
-12,340
-4,041
-2,828
-
Depreciation & amortization
97
97
89
3
3
-
Stock based compensation
2,798
2,798
5,105
4,159
2,061
-
Change in working capital
1,908
1,908
750
273
71
-
Accounts Payable
961
961
459
-16
32
-
Other working capital
-8,481
-8,481
-7,656
-1,556
-704
-
Other non-cash items
402
402
-24
791
-2
-
Net cash provided by operating activites
-8,452
-8,452
-7,586
-1,539
-695
-
Cash flows from investing activities
Investments in property, plant and equipment
-29
-29
-70
-17
-9
-
Purchases of investments
-
-
-3,500
0
0
-
Other investing activites
-3
-3
-20
-
-
-19
Net cash used for investing activites
3,646
3,646
-3,541
-17
-9
-
Cash flows from financing activities
Debt repayment
-80
-80
-79
0
0
-
Common stock issued
3,970
3,970
0
9,864
508
-
Other financing activites
-
-
-
800
-
-
Net cash used privided by (used for) financing activities
3,895
3,895
3,695
11,902
508
-
Net change in cash
-903
-903
-7,520
10,364
-196
-
Cash at beginning of period
3,543
3,543
11,063
699
895
-
Cash at end of period
2,640
2,640
3,543
11,063
699
-
Free Cash Flow
Operating Cash Flow
-8,452
-8,452
-7,586
-1,539
-695
-
Capital Expenditure
-29
-29
-70
-17
-9
-
Free Cash Flow
-8,481
-8,481
-7,656
-1,556
-704
-